Ignite Creation Date:
2024-05-06 @ 8:22 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06352554
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-09
First Post:
2024-04-02
Brief Title:
Susceptibility Testing In Neisseria Gonorrhoeae STING Study Assessing the Performance of a New Rapid Test for Gonorrhoea Antibiotic Resistance in a Cohort of 100 Culture Positive Neisseria Gonorrhoeae Infections
Sponsor:
SpeeDx Pty Ltd
Organization:
SpeeDx Pty Ltd
Study Overview
Official Title:
Susceptibility Testing In Neisseria Gonorrhoeae STING Study
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
STING
Brief Summary:
This study aims to validate a novel antibiotic susceptibility test InSignia for gonorrhoea in patient clinical samples
The hypothesis is that the InSignia test will be able to detect transcriptional responses after incubation in antibiotic for susceptible strains and not resistant strains
Furthermore this study will also add to our understanding on the performance of this test in various clinical specimens
The hypothesis is that the InSignia test will be able to detect transcriptional responses after incubation in antibiotic for susceptible strains and not resistant strains
Furthermore this study will also add to our understanding on the performance of this test in various clinical specimens
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 224842Z21Z | OTHER_GRANT | None | None |
| 75A50122C00028 | OTHER_GRANT | HHSBARDA OTA | None |